IND application submission to the U.S. Food and Drug Administration (FDA) is a pivotal step in initiating a Phase 2/3 clinical study for NUZ-001 The IND is a comprehensive dossier of information, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results